DMTs are expected to account for 73.5% of the global market. The global Alzheimer's disease (AD) market across the eight ...

To date, Leqembi has been approved in the US, Japan, China, South Korea, Hong Kong, Israel, UAE, GB, Mexico, and Macau, and ...

More drugs are scheduled to get cheaper in the following years ... A CT man learned to visit the world of people with ...